Surgical lung biopsy in onco‑hematological patients with diffuse pulmonary infiltrates and mechanical ventilation in the ICU

Cardoso,Eduardo  Mantovani; Bueno,Alexandre  Galvão; Pavan,Daniel  Augusto; Cunha,Ademar    Dantas; Schmidt,Raysa  Cristina; Duarte,Péricles  A.D.

doi:10.3892/ol.2019.10065

Surgical lung biopsy in onco‑hematological patients with diffuse pulmonary infiltrates and mechanical ventilation in the ICU

Authors:
- Eduardo Mantovani Cardoso
- Alexandre Galvão Bueno
- Daniel Augusto Pavan
- Ademar Dantas Cunha
- Raysa Cristina Schmidt
- Péricles A.D. Duarte
View Affiliations

Affiliations: Department of Critical Care Medicine, Hospital do Câncer/UOPECCAN, Cascavel, Paraná 85806‑300, Brazil, Department of Pathology, Hospital do Câncer/UOPECCAN, Cascavel, Paraná 85806‑300, Brazil, Department of Thoracic Surgery, Hospital do Câncer/UOPECCAN, Cascavel, Paraná 85806‑300, Brazil, Department of Oncology, Hospital do Câncer/UOPECCAN, Cascavel, Paraná 85806‑300, Brazil
Published online on: February 21, 2019 https://doi.org/10.3892/ol.2019.10065
Pages: 3997-4003

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Among onco‑hematological patients with acute respiratory failure (ARpF), surgical lung biopsy (SLB) could contribute to the medical management, by guiding initiation, maintenance or discontinuation of diagnostic and therapeutic interventions. The aim of the present study was to evaluate the results of SLB in these patients in an oncological center from a medium‑income country, as well as analyze if this procedure is clinically useful in this context, and its impact on complications and mortality. This observational retrospective study analyzed onco‑hematological patients with ARpF in the Intensive Care Unit (ICU) of a cancer center in southern Brazil between 2010‑2016, who required mechanical ventilation and were submitted to open SLB. Among the studied population (n=17), the most commonly found etiology was infectious, present in ~50% of the biopsies, followed by unspecific inflammatory infiltrate acute respiratory distress syndrome and interstitial fibrosis, alveolar hemorrhage, neoplastic infiltrate and pulmonary embolism. Biopsy has led to a change of management in 63.3% of patients that were alive when results were available; however, 35% of patients succumbed prior to the pathological result. There was no requirement for re‑operation or mortality attributable to the procedure. However, ICU mortality was elevated (88%). SLB in onco‑hematological patients mechanically ventilated in the ICU is a safe procedure with few severe complications and that contributes for diagnosis and management in the majority of cases. Due to the high mortality of this population, controlled trials may be required to establish its benefit in mortality and ICU outcomes.

View Figures

View References

1	Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 v1.0. Int Agency Res Cancer Lyon, France: 2013
2	Brenner H: Long-term survival rates of cancer patients achieved by the end of the 20th century: A period analysis. Lancet. 360:1131–1135. 2002. View Article : Google Scholar : PubMed/NCBI
3	Angus DC, Barnato AE, Linde-Zwirble WT, Weissfeld LA, Watson RS, Rickert T and Rubenfeld GD; Robert Wood Johnson Foundation ICU End-Of-Life Peer Group, : Use of intensive care at the end of life in the United States: An epidemiologic study. Crit Care Med. 32:638–43. 2004. View Article : Google Scholar : PubMed/NCBI
4	Schellongowski P, Sperr WR, Wohlfarth P, Knoebl P, Rabitsch W, Watzke HH and Staudinger T: Critically ill patients with cancer: Chances and limitations of intensive care medicine-a narrative review. ESMO Open. 1:e0000182016. View Article : Google Scholar : PubMed/NCBI
5	Nazer L, Al-Shaer M and Hawari F: Drug utilization pattern and cost for the treatment of severe sepsis and septic shock in critically ill cancer patients. Intern J Clin Pharm. 35:1245–1250. 2013. View Article : Google Scholar
6	Groeger JS, Glassman J, Nierman DM, Wallace SK, Price K, Horak D and Landsberg D: Probability of mortality of critically ill cancer patients at 72 h of intensive care unit (ICU) management. Support Care Canc. 11:686–695. 2003. View Article : Google Scholar
7	Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA and Colardyn FA: Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med. 31:104–112. 2003. View Article : Google Scholar : PubMed/NCBI
8	Pastores SM and Voigt LP: Acute respiratory failure in the patient with cancer: Diagnostic and management strategies. Crit Care Clin. 26:21–40. 2010. View Article : Google Scholar : PubMed/NCBI
9	Cooke CR: Economics of mechanical ventilation and respiratory failure. Crit Care Clin. 28:39–55. 2012. View Article : Google Scholar : PubMed/NCBI
10	Vadde R and Pastores SM: Management of acute respiratory failure in patients with hematological malignancy. J Intens Care Med. 31:627–641. 2016. View Article : Google Scholar
11	Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A, Vincent F, Gruson D, Bruneel F, Epinette-Branche G, et al: Diagnostic strategy for hematology and oncology patients with acute respiratory failure: Randomized controlled trial. Am J Respir Crit Care Med. 182:1038–1046. 2010. View Article : Google Scholar : PubMed/NCBI
12	Azoulay E and Schlemmer B: Diagnostic strategy in cancer patients with acute respiratory failure. Intens Care Med. 32:808–822. 2006. View Article : Google Scholar
13	ARDS Definition Task Force, ; Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L and Slutsky AS: Acute respiratory distress syndrome: The Berlin definition. JAMA. 307:2526–2533. 2012.PubMed/NCBI
14	Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG and Levin A; Acute Kidney Injury Network, : Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 11:R312007. View Article : Google Scholar : PubMed/NCBI
15	Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 315:801–810. 2016. View Article : Google Scholar : PubMed/NCBI
16	Gay J, Lemiale V, Meignin V, Bron C, De Bazelaire C, Schnell D, Canet E, Seguin A and Azoulay E: Diagnostic contribution from pulmonary biopsies in hematology patients with acute respiratory failure from undetermined etiology. Minerva Anestesiol. 79:853–860. 2013.PubMed/NCBI
17	Zihlif M, Khanchandani G, Ahmed HP and Soubani AO: Surgical lung biopsy in patients with hematological malignancy or hematopoietic stem cell transplantation and unexplained pulmonary infiltrates: Improved outcome with specific diagnosis. Am J Hematol. 78:94–99. 2005. View Article : Google Scholar : PubMed/NCBI
18	White DA, Wong PW and Downey R: The utility of open lung biopsy in patients with hematologic malignancies. Am J Resp Crit Care Med. 161:723–729. 2000. View Article : Google Scholar : PubMed/NCBI
19	Snyder CL, Ramsay NK, Mcglave PB, Ferrell KL and Leonard AS: Diagnostic open-lung biopsy after bone marrow transplantation. J Pediatr Surg. 25:871–877. 1990. View Article : Google Scholar : PubMed/NCBI
20	Kramer MR, Berkman N, Mintz B, Godfrey S, Saute M and Amir G: The role of open lung biopsy in the management and outcome of patients with diffuse lung disease. Ann Thor Surg. 65:198–202. 1998. View Article : Google Scholar
21	Hayes-Jordan A, Benaim E, Richardson S, Joglar J, Srivastava DK, Bowman L and Shochat SJ: Open lung biopsy in pediatric bone marrow transplant patients. J Pediatr Surg. 37:446–452. 2002. View Article : Google Scholar : PubMed/NCBI
22	Gerard L, Bidoul T, Castanares-Zapatero D, Wittebole X, Lacroix V, Froidure A, Hoton D and Laterre PF: Open lung biopsy in nonresolving acute respiratory distress syndrome commonly identifies corticosteroid-sensitive pathologies, associated with better outcome. Crit Care Med. 46:907–914. 2018. View Article : Google Scholar : PubMed/NCBI
23	Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J and Cardinaud JP: Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med. 344:481–487. 2001. View Article : Google Scholar : PubMed/NCBI
24	Rudd KE, Kissoon N, Limmathurotsakul D, Bory S, Mutahunga B, Seymour CW, Angus DC and West TE: The global burden of sepsis: Barriers and potential solutions. Crit Care. 22:2322018. View Article : Google Scholar : PubMed/NCBI
25	Becker JU, Theodosis C, Jacob ST, Wira CR and Groce NE: Surviving sepsis in low-income and middle-income countries: New directions for care and research. Lancet Infect Dis. 9:577–582. 2009. View Article : Google Scholar : PubMed/NCBI
26	Laffey J, Madotto F, Bellani G, Pham T, Fan E, Brochard L, Amin P, Arabi Y, Bajwa EK, Bruhn A, et al: Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: Insights from the LUNG SAFE prospective cohort study. Lancet Resp Med. 5:627–638. 2017. View Article : Google Scholar